Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2014
04/01/2014US8685407 Genetic constructs and compositions comprising RRE and CTE and uses thereof
04/01/2014US8685405 Immunization of fish with plant-expressed recombinant proteins
04/01/2014US8685403 Insulin-like growth factor signaling and integrin
04/01/2014US8685398 Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/01/2014US8685397 Combination therapy for the treatment of ocular neovascular disorders
04/01/2014US8685384 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
04/01/2014CA2708549C Bmp mutants with decreased susceptibility to noggin
04/01/2014CA2661995C Antigenic protein conjugates and process for preparing same
04/01/2014CA2577632C Intestinal epithelial glucose sensor
04/01/2014CA2567478C Labelled adrenomedullin derivatives and their use for imaging and therapy
04/01/2014CA2544692C Anti-glypican 3 antibody
04/01/2014CA2531231C Uranium-chelating peptides and uses thereof
04/01/2014CA2504920C Ligand for g-protein coupled receptor fprl2 and uses thereof
04/01/2014CA2493928C Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
04/01/2014CA2488682C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/01/2014CA2486483C Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/01/2014CA2465792C Non-neurotoxic plasminogen activating factors for treating of stroke
04/01/2014CA2433561C Compositions including gram negative siderophore receptor proteins and methods of use
04/01/2014CA2420062C Erbb4 antagonists
04/01/2014CA2296689C Increasing production of proteins in gram-positive microorganisms
03/2014
03/27/2014WO2014047285A1 Identifying taxane sensitivity in prostate cancer patients
03/27/2014WO2014047194A1 Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
03/27/2014WO2014046994A1 Compositions and methods for antigen targeting to cd180
03/27/2014WO2014046966A1 Beclin 1 phosphorylation
03/27/2014WO2014046732A1 Cyclotide-based cxcr4 antagonists with anti-hiv activity
03/27/2014WO2014046731A1 Preparation of cyclotides
03/27/2014WO2014046490A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046478A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
03/27/2014WO2014046423A1 Peptide having cancer selective translocation function and use thereof
03/27/2014WO2014046410A1 Method for producing virus-like particles of nodavirus, yeast cell line expressing same, and vaccine composition containing same
03/27/2014WO2014046278A1 Protein ligand for affinity isolation matrix
03/27/2014WO2014046247A1 Synthetic peptide for adjusting balance of type-1 tnf receptors and type-2 tnf receptors, and use of said peptide
03/27/2014WO2014046125A1 Prevention/treatment agent for pulmonary hypertension comprising thrombin receptor antagonist as active component
03/27/2014WO2014046045A1 Method for detecting hcv in blood, and method for determining effect of anti-hcv treatment
03/27/2014WO2014045621A1 Pneumococcal vaccine containing pneumococcal surface protein a
03/27/2014WO2014045310A1 Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer
03/27/2014WO2014045226A1 Clostridium difficile polypeptides as vaccine
03/27/2014WO2014045084A1 Fusion proteins with representation of different allergens: vaccine proposal for mite allergies
03/27/2014WO2014044793A2 Cd22-binding peptides
03/27/2014WO2014044758A1 Novel il-17a binding molecules and medical uses thereof
03/27/2014WO2014044708A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/27/2014WO2014044640A1 Modified fungal cell
03/27/2014WO2014044184A1 Protein for detecting type 1 diabetes mellitus and partial peptide thereof
03/27/2014WO2014043871A1 Use of pedf-derived polypeptides for treating osteoarthritis
03/27/2014WO2014043861A1 Use of pedf-derived polypeptides for preventing and/or ameliorating skin aging
03/27/2014WO2014043813A1 Immune repertoire profiling
03/27/2014WO2014024090A3 Fungal resistant plants expressing hcp5
03/27/2014WO2014020533A3 Novel enzymes, enzyme components and uses thereof
03/27/2014WO2014020291A3 Mutant strains of neospora and uses thereof
03/27/2014WO2013177398A3 Non-natural consensus albumin binding domains
03/27/2014WO2011005566A3 Aptamer-targeted sirna to inhibit nonsense mediated decay
03/27/2014US20140090114 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
03/27/2014US20140090103 Methods and compositions for increasing plant disease resistance and yield
03/27/2014US20140088294 Production of glycoproteins using manganese
03/27/2014US20140088293 Photosynthetic organisms and compositions and methods of generating same
03/27/2014US20140088292 Water-Soluble Polypeptides Comprised of Repeat Modules, Method for Preparing the Same and Method for a Target-Specific Polypeptide and Analysis of Biological Activity Thereof
03/27/2014US20140088026 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088025 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088024 Vesiculins
03/27/2014US20140088019 Monovalent and Multivalent Multispecific Complexes and Uses Thereof
03/27/2014US20140088018 Compositions and methods for treatment of gynecologic cancers
03/27/2014US20140088015 Mucin 3 EGF-like Domains
03/27/2014US20140088008 Novel activin receptor and uses thereof
03/27/2014US20140088005 Double-acylated glp-1 derivatives
03/27/2014US20140088003 Polymer-based sustained release device
03/27/2014US20140087995 Polypeptides
03/27/2014US20140087993 Pepducin design and use
03/27/2014US20140087441 Novel application of fibrinogen-420 and its active domain
03/27/2014US20140087422 Nucleic acids related to fusion proteins
03/27/2014US20140087399 Assay method for peptide specific t-cells
03/27/2014US20140087395 Method for distinguishing between species within the genus staphilococcus
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140086988 Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them
03/27/2014US20140086953 Attenuated chikungunya virus
03/27/2014US20140086949 Ghrelin Mimetic Polypeptide Hapten Immunoconjugates Having Improved Solubility and Immunogenicity and Methods of Use Thereof
03/27/2014US20140086947 Vaccines for hsv-2
03/27/2014US20140086946 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum
03/27/2014US20140086924 Compounds that inhibit hsp90 protein-protein interactions with iap proteins
03/27/2014US20140086907 Multimodal trail molecules and uses in cellular therapies
03/27/2014US20140086885 Methods and compositions for targeted cleavage and recombination
03/27/2014US20140086871 Ultralong complementarity determining regions and uses thereof
03/27/2014US20140086846 Contrast enhancement agents and method of use thereof
03/27/2014US20140086835 Methods and Compositions for Heptameric Targeting Ligands
03/27/2014US20140085998 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
03/27/2014US20140083945 Reducing Soluble Urokinase Receptor in the Circulation
03/26/2014EP2711436A1 Recombinant factor VIII having increased stability
03/26/2014EP2711427A1 HCV gene
03/26/2014EP2711375A1 Human Antigen Binding Proteins that bind Beta-Klotho, FGF Receptors and complexes thereof
03/26/2014EP2711374A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
03/26/2014EP2711025A2 Self-assembling peptides incorporating modifications and methods of use thereof
03/26/2014EP2711016A1 Novel IL-17A binding molecules and medical uses thereof
03/26/2014EP2710128A1 Plants having enhanced abiotic stress resistance
03/26/2014EP2710125A1 Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment
03/26/2014EP2710031A2 Improved peptide pharmaceuticals for insulin resistance
03/26/2014EP2710030A1 Rbm3 in bladder cancer
03/26/2014EP2710029A1 New chymase binding compounds and medical uses thereof
03/26/2014EP2710028A1 Pathogenic bacteria
03/26/2014EP2709728A1 Tau protease compositions and methods of use
03/26/2014EP2709671A1 Method
03/26/2014EP2709653A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 2916